Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Muscle function recovery after deep neuromuscular blockade: sugammadex vs neostigmine
2013-004787-62Phase 4Completed
- Sponsor
- SOD Anestesia e Terapia Intensiva, DAI Oncologia, AOU Careggi, Firenze
- Start
- Jun 2014
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial in neuromuscular block (NMB) and None comparing Sugammadex arm with Neostigmine + atropine arm (2 arms). Primary endpoint: reduction of curarization. Started Jun 2014; status: completed.
02
Drugs
Sugammadexneostigmine
03
Conditions
neuromuscular block (NMB)
Beyond the preview
Go deeper on 2013-004787-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004787-62.